Emilio Ciusani Selected Research

BNT162 Vaccine

2/2022

Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emilio Ciusani Research Topics

Disease

35	Neoplasms (Cancer) 01/2021 - 02/2004
18	Glioma (Gliomas) 05/2021 - 03/2002
10	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 03/2002
6	Carcinoma (Carcinomatosis) 12/2021 - 03/2006
6	Melanoma (Melanoma, Malignant) 05/2021 - 12/2010
4	Multiple Sclerosis 02/2022 - 06/2002
4	Inflammation (Inflammations) 12/2021 - 09/2013
4	Pancreatic Neoplasms (Pancreatic Cancer) 02/2019 - 12/2015
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2019
2	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 01/2017 - 03/2012
2	Drug Resistant Epilepsy 01/2017 - 03/2011
2	Seizures (Absence Seizure) 01/2017 - 03/2011
2	Neoplasm Metastasis (Metastasis) 08/2015 - 01/2009
2	Demyelinating Diseases (Demyelinating Disease) 09/2013 - 02/2006
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2021
1	Mesothelioma 12/2021
1	Ketosis 01/2021
1	Epilepsy (Aura) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Disease Susceptibility (Diathesis) 03/2019
1	Disease Progression 03/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2019
1	Necrosis 12/2018
1	Muscle Spasticity (Spastic) 08/2018
1	Meningioma (Meningiomas) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Prescription Drug Overuse 05/2017
1	Pain (Aches) 05/2017
1	Migraine Disorders (Migraine) 05/2017

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 11/2017 - 03/2006
10	Paclitaxel (Taxol)FDA LinkGeneric 02/2019 - 01/2011
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 02/2004
5	Conditioned Culture MediaIBA 03/2015 - 01/2011
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2008
4	LigandsIBA 12/2021 - 01/2005
4	Temozolomide (Temodar)FDA LinkGeneric 05/2021 - 01/2004
4	Biomarkers (Surrogate Marker)IBA 03/2019 - 12/2010
3	Antineoplastic Agents (Antineoplastics)IBA 12/2021 - 01/2006
3	Drug CombinationsIBA 05/2021 - 06/2014
3	EnzymesIBA 05/2021 - 02/2006
3	Histone Deacetylase InhibitorsIBA 01/2020 - 06/2011
3	PlatinumIBA 07/2019 - 01/2018
3	Biological ProductsIBA 03/2019 - 03/2015
3	matrigelIBA 01/2017 - 01/2006
3	AntibodiesIBA 01/2016 - 09/2012
3	ChemokinesIBA 06/2014 - 06/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 01/2005
3	Plasminogen Activator Inhibitor 1IBA 02/2006 - 02/2004
2	Immunoglobulin G (IgG)IBA 02/2022 - 09/2013
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 06/2014
2	Cisplatin (Platino)FDA LinkGeneric 07/2019 - 01/2018
2	CytokinesIBA 01/2019 - 01/2014
2	IntegrinsIBA 12/2018 - 01/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017 - 06/2014
2	MicroRNAs (MicroRNA)IBA 01/2017 - 10/2015
2	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2011 - 05/2004
2	HomocysteineIBA 05/2008 - 02/2004
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2005 - 01/2004
2	Topoisomerase I InhibitorsIBA 01/2005 - 03/2002
1	BNT162 VaccineIBA 02/2022
1	VaccinesIBA 02/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2022
1	LipidsIBA 12/2021
1	8-aminoquinolineIBA 12/2021
1	Orlistat (Xenical)FDA Link 05/2021
1	VemurafenibIBA 05/2021
1	perampanelIBA 05/2021
1	Glutamate Receptors (Glutamate Receptor)IBA 05/2021
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	KetonesIBA 01/2021
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2021
1	isospaglumic acid (NAAGA)IBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Histone Deacetylase 6IBA 01/2020
1	AZD 6244IBA 01/2020
1	ricolinostatIBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Cystatin BIBA 01/2020
1	Polystyrenes (Polystyrene)IBA 11/2019
1	SB 203580IBA 07/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2019
1	statticIBA 07/2019
1	PorphyrinsIBA 01/2019
1	T 0070907IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	marycinIBA 01/2019
1	ProteomeIBA 01/2019
1	Nucleosomes (Nucleosome)IBA 12/2018
1	AnnexinsIBA 12/2018
1	Type A Botulinum Toxins (Botox)FDA Link 08/2018
1	selinexorIBA 01/2018
1	Complex MixturesIBA 05/2017
1	pantothenate kinaseIBA 01/2017

Therapy/Procedure

11	Therapeutics 02/2022 - 03/2002
5	Drug Therapy (Chemotherapy) 12/2018 - 01/2007
3	Ketogenic Diet 01/2021 - 01/2014
3	Radiotherapy 01/2018 - 05/2012
1	Castration 01/2020